Company
Vision
Granlen seeks to become the leading global life science outsourcing company, renowned for its outstanding quality, expertise, and culture. We are committed to building an organization that defines best-in-class in each of these areas. Clients’ satisfaction is our goal. Our top priority is to provide high quality services at an effective cost. We are committed to the success of our clients by providing world-class pharmaceutical R&D services: from chemistry through IND. Our clients’ success is our success.
Granlen's path to success is predicated on the following:
- Striving for customers’ success. We are fully committed to ensuring the success of our customers through our highly experienced people and stringent project management. Granlen seeks to be recognized for always exceeding expectations.
- Building an outstanding team. We seek to attract the best talents worldwide, and to empower them with the continual learning environment. Building on a service philosophy to optimize quality, efficiency and cost utilizing our flexible and innovative scientific expertise.
- Broad experience. Granlen's team contains a broad spectrum of deep experiences across drug discovery and development through IND including organic synthesis, medicinal chemistry, process development and large scale synthesis, analytical, pharmaceutical science, drug design, drug discovery and development, IND documentation and application.
- Distinguishable Specialty. We are specialized in nucleosides, nucleotides, phosphates, phosphonates, dinucleotides, triphosphates, phosphoramidites, polyamines and guanidines, immunogens, bioreagents, and superchelating agents.
Granlen's founders, management team, and scientific leaders are all extremely successful and are respected world-wide as individuals with an impressive track record of producing high quality science and building high quality organizations.